CA224

CA224 (Compound 1) is an orally bioavailable, selective inhibitor of the Cdk4/cyclin D1 complex with an IC50 of 6.2 μM. This small molecule induces apoptosis and demonstrates antitumor activity, supporting its use in cancer research for both in vitro mechanistic studies and in vivo efficacy models.